Drug Availability

 

HPS Pharmacies wish to give notice that Sanofi-Aventis Australia Pty Ltd are currently experiencing an interruption to the supply of Sofradex® and Otodex® Ear Drops as follows:

Sofradex® Ear Drops
Dexamethasone, Framycetin sulfate, Gramicidin
ARTG 13539

Otodex® Ear Drops
Dexamethasone, Framycetin sulfate, Gramicidin
ARTG 43840

The supply interruption is due to manufacturing issues. Normal supplies are expected to resume in September 2017.

Alternative products that may be considered include:

Sofradex®
Otodex®

Soframycin®

 

Otocomb Otic®
Kenacomb Otic®

 

Presentation

8ml

8ml

7.5ml

PBS subsidised

Yes

Yes

Yes

Route

Ear

Eye/Ear

Ear

Dexamethasone

0.05%

Framycetin sulfate

0.5%

0.05%

Gramicidin

0.005%

0.025%

Triamcinolone acetonide

0.1%

Neomycin sulfate

0.25%

Nystatin

100,000 units/gram

 

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Sanofi-Aventis Australia on (02) 8666 2000.

Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates